| abstract |
Disclosed in the present invention are an application of lysozyme or a combination comprising the lysozyme in preparation of a medicine for preventing or treating COVID-19, and an application in preparation of food for assisting in preventing or treating COVID-19. The lysozyme or the combination thereof provided by the present invention can effectively inhibit cell damage caused by novel coronavirus, inhibit inflammatory factor expression induced by novel coronavirus, improve airway obstruction and expiratory volume reduction caused by pulmonary lesions, and improve intestinal barrier dysfunction. The lysozyme or the combination thereof has a good effect on high virus load, respiratory distress, intestinal function impairment and the like of patients, and can reduce the infection rate of novel coronavirus and severe cases of COVID-19. In addition, because the lysozyme is extremely high in safety, the lysozyme also has a very important value for preventing unconfirmed people at a high risk for infection from infecting novel coronavirus. |